DURHAM, État de Caroline du Nord, 28 juin 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq : FTRE), un organisme de recherche sous contrat (« ORC ») de premier plan au niveau mondial, a [...] Read more »
Fortrea startet KI-Innovationsstudio, um Technologie und menschliche Lösungen zur Verbesserung der Durchführung klinischer Studien zu bündeln
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), ein führendes globales Auftragsforschungsinstitut (CRO), gab heute die Einführung seines Innovationsstudios für künstliche Intelligenz (KI) [...] Read more »
Fortrea Lança AI Innovation Studio para Galvanizar Tecnologia e Soluções Humanas para Aprimoramento da Entrega de Ensaios Clínicos
DURHAM, N.C., June 28, 2024 (GLOBE NEWSWIRE) — A Fortrea (Nasdaq: FTRE), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje o lançamento do seu AI Innovation Studio, [...] Read more »
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI) Innovation Studio, signaling a [...] Read more »
Adalvo erhält erste Generika-Zulassung in der EU für Liraglutid-Fertigpen
SAN ĠWANN, Malta, June 17, 2024 (GLOBE NEWSWIRE) — Adalvo gibt die erfolgreiche DCP–Zulassung für Liraglutid–Fertigpens und damit die erste Generika–Zulassung in der EU bekannt.
Als [...] Read more »
Adalvo obtient la première approbation générique de l’UE pour son stylo prérempli de liraglutide
SAN ĠWANN, Malte, 17 juin 2024 (GLOBE NEWSWIRE) — Adalvo annonce l’approbation par procédure décentralisée de son stylo prérempli de liraglutide, soit la toute première approbation [...] Read more »
Adalvo obtém primeira aprovação genérica da UE para caneta pré-cheia com liraglutida
SAN ĠWANN, Malta, June 17, 2024 (GLOBE NEWSWIRE) — Adalvo anuncia a aprovação bem–sucedida do DCP para a caneta pré–cheia com liraglutida, marcando–a como a primeira aprovação [...] Read more »
Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre–filled pen, marking it as the first generic approval in the EU.
As a bioequivalent version of [...] Read more »
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries
SALT LAKE CITY, June 11, 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea Finaliza Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
DURHAM, N.C., June 05, 2024 (GLOBE NEWSWIRE) — A Read more »